ArticleJAMA network open2025

Combination of Glucagon-Like Peptide 1 Receptor Agonist and Thiazolidinedione for Mortality and Cardiovascular Outcomes in Patients With Type 2 Diabetes.

Jing-Xing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.